{
  "url": "https://openlegislation.uk/infant-formula-and-follow-on-formula-wales-regulations-2020/regulation-5",
  "json_url": "https://openlegislation.uk/infant-formula-and-follow-on-formula-wales-regulations-2020/regulation-5.json",
  "legislation": "wsi/2020/89",
  "legislation_title": "The Infant Formula and Follow-on Formula (Wales) Regulations 2020",
  "legislation_url": "https://openlegislation.uk/infant-formula-and-follow-on-formula-wales-regulations-2020",
  "path": "regulation/5",
  "kind": "regulation",
  "number": "5",
  "heading": "Revocations, savings and transitional provisions",
  "text": "(1) The instruments specified in column 1 of the table in Schedule 3 are revoked to the extent specified in column 3 of that table, subject to paragraph (2).\n(2) The instruments specified in column 1 of the table in Schedule 3 continue to have effect (so far as otherwise revoked to the extent specified in column 3 of that table)—\n(a) until 21 February 2021 in respect of infant formula and follow-on formula manufactured from protein hydrolysates;\n(b) for the purposes of paragraph (3)(b).\n(3) Infant formula and follow-on formula which does not comply with a specified EU law requirement may continue to be marketed until stocks of such food are exhausted, provided that—\n(a) it was placed on the market or labelled—\n(i) before 22 February 2020; or\n(ii) before 22 February 2021 in the case of infant formula and follow-on formula manufactured from protein hydrolysates; and\n(b) the conditions specified in the following provision of the Infant Formula and Follow-on Formula (Wales) Regulations 2007 are met—\n(i) regulation 3(1) (prohibition on the marketing of infant formula unless certain conditions are met) in the case of infant formula;\n(ii) regulation 3(2) (prohibition on the marketing of follow-on formula unless certain conditions are met) in the case of follow-on formula.\n(4) Regulations 2 to 4 do not apply in respect of infant formula and follow-on formula manufactured from protein hydrolysates until 22 February 2022.\n(5) Schedule 4 makes provision in relation to infant formula and follow-on formula manufactured from protein hydrolysates until 22 February 2022.",
  "extent": "E+W",
  "status": null,
  "version": "current",
  "annotations": [
    {
      "type": "F",
      "label": "F1",
      "text": "Reg. 5(4)(5) inserted (16.9.2021) by The Infant Formula and Follow-on Formula (Wales) (Amendment) Regulations 2021 (S.I. 2021/955), regs. 1(2), 2(2)"
    },
    {
      "type": "M",
      "label": "M1",
      "text": "S.I. 2007/3573 (W. 316). The relevant amending instrument is S.I. 2008/2602 (W. 228)."
    },
    {
      "type": "I",
      "label": "I1",
      "text": "Reg. 5 in force at 22.2.2020 for specified purposes and at 22.2.2021 in so far as not already in force, see reg. 1(2)"
    }
  ],
  "outstanding_effects": [],
  "provenance": {
    "source": "legislation.gov.uk",
    "source_url": "https://www.legislation.gov.uk/wsi/2020/89/regulation/5",
    "retrieved_at": "2026-10-28T23:17:38.828988+00:00"
  },
  "licence": "Open Government Licence v3.0",
  "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/",
  "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives."
}